Violetta S. Gogoleva

Ms. Violetta S. Gogoleva

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KAKamar-Sulu N. Atretkhany
Kamar-Sulu N. Atretkhany
IMIlgiz A. Mufazalov
Ilgiz A. Mufazalov
JDJosefine Dunst
Josefine Dunst
AKAnna Kuchmiy
Anna Kuchmiy
VGVioletta S. Gogoleva
Violetta S. Gogoleva
SNSergei A. Nedospasov
Sergei A. Nedospasov
Significance: In spite of TNF involvement in the pathogenesis of multiple sclerosis (MS), systemic TNF neutralization in MS patients was not successful. One of the possible reasons is that TNF possesses both pathogenic and protective features that may be related to TNFR1 versus TNFR2 receptor engagement. This study uncovers one of such protective functions of TNF mediated by intrinsic TNFR2 signaling in Tregcells. In mice bearing humanized TNF and TNFR2 genetic loci, TNFR2 ablation restricted to Tregcells led to reduced capacity to control Th17 cell responses, exacerbated experimental autoimmune encephalomyelitis (EAE) development, and affected the maintenance of Tregcells. These findings provide support for the emerging role of TNFR2 signaling in autoimmunity, as demonstrated here in mice with conditional inactivation of TNFR2.

13 May 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
VGVioletta S. Gogoleva
Violetta S. Gogoleva
KAKamar-Sulu N. Atretkhany
Kamar-Sulu N. Atretkhany
ADArina P. Dygay
Arina P. Dygay
TYTaisiya R. Yurakova
Taisiya R. Yurakova
MDMarina S. Drutskaya
Marina S. Drutskaya
SNSergei A. Nedospasov
Sergei A. Nedospasov
TNF is a multifunctional cytokine with its key functions attributed to inflammation, secondary lymphoid tissue organogenesis and immune regulation. However, it is also a physiological regulator of hematopoiesis and is involved in development and homeostatic maintenance of various organs and tissues. Somewhat unexpectedly, the most important practical application of TNF biology in medicine is anti-TNF therapy in several autoimmune diseases. With increased number of patients undergoing treatment with TNF inhibitors and concerns regarding possible adverse effects of systemic cytokine blockade, the interest in using humanized mouse models to study the efficacy and safety of TNF-targeting biologicsin vivois justified. This Perspective discusses the main functions of TNF and its two receptors, TNFR1 and TNFR2, in steady state, as well as in emergency hematopoiesis. It also provides a comparative overview of existing mouse lines with humanization of TNF/TNFR system. These genetically engineered mice allow us to study TNF signaling cascades in the hematopoietic compartment in the context of various experimental disease models and for evaluating the effects of various human TNF inhibitors on hematopoiesis and other physiological processes.

29 August 2024 in European Journal of Immunology
Verified
Journal Article
Closed access
VGVioletta S. Gogoleva
Violetta S. Gogoleva
MDMarina S. Drutskaya
Marina S. Drutskaya
AVAlexander I. Vorontsov
Alexander I. Vorontsov
KAKamar‐Sulu N. Atretkhany
Kamar‐Sulu N. Atretkhany
ABAlexey A. Belogurov
Alexey A. Belogurov
SNSergei A. Nedospasov
Sergei A. Nedospasov